Retinal Investigation Using Optos OCT Device

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOptos, PLC

About this trial

Retinal investigation using OCT with control and diseased eyes

Eligibility criteria

Qualifiers

Male or female participants 18 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.

Participants who understand the study and patient information sheet and can follow the instructions.

Participants who agree to participate in the study.

Control group where no retinal abnormalities were detected as part of the standard basic ophthalmic examination.

Disqualifiers

Inability to understand written and verbal English sufficiently to comprehend the study and provide informed consent

Ophthalmic disease other than condition under investigation.

Participants unable to tolerate ophthalmic imaging.

Cataract (unless deemed mild in the opinion of the investigator)

Trial design

Treatments tested in this trial

  • retinal functional imaging

Treatment groups

120 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators